Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604244.pdf
Reference30 articles.
1. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21: 3431–3439
2. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I – The analysis of case–control studies. IARC Sci Publ 32: 5–338
3. Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM (2006) Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 17: 785–793
4. Dershaw DD, Yahalom J, Petrek JA (1992) Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology 184: 421–423
5. Devita Jr VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73: 881–895
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy;Journal of Clinical Oncology;2022-05-01
2. Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors;Critical Reviews in Oncology/Hematology;2021-01
3. Second Malignancy Risk After Treatment of Hodgkin Lymphoma;Hodgkin Lymphoma;2020
4. Late Effects in Pediatric Acute Lymphoblastic Leukemia;Pediatric Acute Lymphoblastic Leukemia;2019-11-27
5. No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy;British Journal of Haematology;2019-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3